These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 14517353)
1. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Bacskai BJ; Hickey GA; Skoch J; Kajdasz ST; Wang Y; Huang GF; Mathis CA; Klunk WE; Hyman BT Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12462-7. PubMed ID: 14517353 [TBL] [Abstract][Full Text] [Related]
2. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073 [TBL] [Abstract][Full Text] [Related]
3. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250 [TBL] [Abstract][Full Text] [Related]
4. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. Bacskai BJ; Kajdasz ST; McLellan ME; Games D; Seubert P; Schenk D; Hyman BT J Neurosci; 2002 Sep; 22(18):7873-8. PubMed ID: 12223540 [TBL] [Abstract][Full Text] [Related]
5. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129 [TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils. Fosso MY; McCarty K; Head E; Garneau-Tsodikova S; LeVine H ACS Chem Neurosci; 2016 Feb; 7(2):171-6. PubMed ID: 26682772 [TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. McLellan ME; Kajdasz ST; Hyman BT; Bacskai BJ J Neurosci; 2003 Mar; 23(6):2212-7. PubMed ID: 12657680 [TBL] [Abstract][Full Text] [Related]
8. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265. Okamura N; Mori M; Furumoto S; Yoshikawa T; Harada R; Ito S; Fujikawa Y; Arai H; Yanai K; Kudo Y J Alzheimers Dis; 2011; 23(1):37-48. PubMed ID: 20930313 [TBL] [Abstract][Full Text] [Related]
9. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models. Schmidt A; Pahnke J J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331 [TBL] [Abstract][Full Text] [Related]
11. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease. Zeng J; Wu J; Li M; Wang P Arch Med Res; 2018 May; 49(4):282-285. PubMed ID: 30266531 [TBL] [Abstract][Full Text] [Related]
12. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. Klunk WE; Bacskai BJ; Mathis CA; Kajdasz ST; McLellan ME; Frosch MP; Debnath ML; Holt DP; Wang Y; Hyman BT J Neuropathol Exp Neurol; 2002 Sep; 61(9):797-805. PubMed ID: 12230326 [TBL] [Abstract][Full Text] [Related]
13. Generation of Clickable Pittsburgh Compound B for the Detection and Capture of β-Amyloid in Alzheimer's Disease Brain. Diner I; Dooyema J; Gearing M; Walker LC; Seyfried NT Bioconjug Chem; 2017 Oct; 28(10):2627-2637. PubMed ID: 28862836 [TBL] [Abstract][Full Text] [Related]
14. Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease. Fu H; Cui M; Zhao L; Tu P; Zhou K; Dai J; Liu B J Med Chem; 2015 Sep; 58(17):6972-83. PubMed ID: 26262759 [TBL] [Abstract][Full Text] [Related]
15. Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease. Friedland RP; Shi J; Lamanna JC; Smith MA; Perry G Ann N Y Acad Sci; 2000 Apr; 903():123-8. PubMed ID: 10818497 [TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of amyloid-beta deposits in mouse brain with multiphoton microscopy. Skoch J; Hickey GA; Kajdasz ST; Hyman BT; Bacskai BJ Methods Mol Biol; 2005; 299():349-63. PubMed ID: 15980616 [TBL] [Abstract][Full Text] [Related]
19. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377 [TBL] [Abstract][Full Text] [Related]
20. Rapid cerebral amyloid binding by Aβ antibodies infused into β-amyloid precursor protein transgenic mice. Winkler DT; Abramowski D; Danner S; Zurini M; Paganetti P; Tolnay M; Staufenbiel M Biol Psychiatry; 2010 Nov; 68(10):971-4. PubMed ID: 20359696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]